Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2. Clin
収録刊行物
-
- Cancer. Res.
-
Cancer. Res. 4 713-720, 1998